The Relative Impact of Anxiety, Depression, and Clinical Seizure Features on Health‐related Quality of Life in Epilepsy
2004/05/01 by Erica K. Johnson, Jana E. Jones, Michael Seidenberg +1 · 29 citations
Medicine · #Epilepsy research and treatment #Psychosomatic Disorders and Their Treatments #Pharmacological Effects and Toxicity Studies
paper · doi:10.1111/j.0013-9580.2004.47003.x
Abstract
PURPOSE: To determine the independent effects of depression and anxiety on health-related quality of life (HRQOL) in epilepsy as well as the relative explanatory power of psychiatric comorbidity compared with demographic and clinical epilepsy variables (e.g., seizure frequency, severity, and chronicity). METHODS: Subjects (n = 87) with temporal lobe epilepsy completed self-report measures of depression, anxiety, HRQOL, and seizure severity. Information was derived regarding subjects' seizure frequency, duration, and treatment. HRQOL status (QOLIE-89) was examined in relation to self-reported symptoms of anxiety and depression, clinical seizure features, and demographic characteristics. RESULTS: Depression and anxiety were independently associated with reduced HRQOL. Psychiatric comorbidity explained more variance in HRQOL than did combined groups of clinical seizure or demographic variables. Although weaker in explanatory power than psychiatric comorbidity, several epilepsy factors were nonetheless significantly related to HRQOL, including seizure frequency, severity, and chronicity. CONCLUSIONS: Interictal anxiety and depression exert independent adverse effects on HRQOL. In addition, frequent, severe, and chronic seizures reduce HRQOL, but appear less powerful predictors of HRQOL than interictal psychiatric symptoms. Recognition and treatment of comorbid depression and anxiety is an important consideration in improving quality of life in epilepsy.
Citations
Cited by
- Anxiety and depressive disorders in people with epilepsy: A meta‐analysis
- Mental health stigma: Impact on mental health treatment attitudes and physical health
- Comorbidities in the mouse model of temporal lobe epilepsy induced by intrahippocampal kainate
- More than seizure control: Multidimensional Outcome Reporting in Epilepsy (MORE) as a patient‐centered framework redefining success in treatment
- Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. [europepmc]
- Kindling epileptogenesis in immature rats leads to persistent depressive behavior. [europepmc]
- Seizures in the elderly: impact on mental status, mood, and sleep. [europepmc]
- Sociodemographic and clinical factors associated with depression in epilepsy. [europepmc]
- Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months. [europepmc]
- Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study. [europepmc]
- Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations. [europepmc]
- The quality of life of people with epilepsy at a tertiary referral centre in Malaysia. [europepmc]
- Parent and family stress factors predict health-related quality in pediatric patients with new-onset epilepsy. [europepmc]
- Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study. [europepmc]
- Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases. [europepmc]
- Targeting the Mouse Ventral Hippocampus in the Intrahippocampal Kainic Acid Model of Temporal Lobe Epilepsy. [europepmc]
- Beyond depression: The impact of executive functioning on quality of life in patients with temporal lobe epilepsy. [europepmc]
- Dog alerting and/or responding to epileptic seizures: A scoping review. [europepmc]
- Epilepsy, depression, and growth hormone. [europepmc]
- The experience of the multidisciplinary team in epilepsy management from a resource-limited country. [europepmc]
- Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy. [europepmc]
- Depression and anxiety in children with epilepsy and other chronic health conditions: National estimates of prevalence and risk factors. [europepmc]
- Network Dysfunction in Comorbid Psychiatric Illnesses and Epilepsy. [europepmc]
- Telehealth in pediatric epilepsy care: A rapid transition during the COVID-19 pandemic. [europepmc]
- Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies. [europepmc]
- The Military Injuries: Understanding Post-Traumatic Epilepsy Study: Understanding Relationships among Lifetime Traumatic Brain Injury History, Epilepsy, and Quality of Life. [europepmc]
- Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention. [europepmc]
- Stress and Epilepsy: Towards Understanding of Neurobiological Mechanisms for Better Management. [europepmc]
- The present and future of seizure detection, prediction, and forecasting with machine learning, including the future impact on clinical trials. [europepmc]
Related